Acute ischemic stroke (AIS) - Epidemiology Forecast to 2032

January 2022 | 60 pages | ID: ACF2380339CEN
DelveInsight

Abstracts

This report can be delivered to the clients within 5-7 Business Days

DelveInsight's 'Acute ischemic stroke (AIS) - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Acute ischemic stroke (AIS) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Geographies Covered

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2019-2032

Acute ischemic stroke (AIS) Understanding

The DelveInsight Acute ischemic stroke (AIS) epidemiology report gives a thorough understanding of the Acute ischemic stroke (AIS) by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Acute ischemic stroke (AIS) in the US, Europe, and Japan. The report covers the detailed information of the Acute ischemic stroke (AIS) epidemiology scenario in seven major countries (US, EU5, and Japan).

Acute ischemic stroke (AIS) Epidemiology Perspective by DelveInsight

The Acute ischemic stroke (AIS) epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Acute ischemic stroke (AIS) epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Acute ischemic stroke (AIS) epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2019 to 2032. It also helps recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Acute ischemic stroke (AIS) Detailed Epidemiology Segmentation

The Acute ischemic stroke (AIS) epidemiology covered in the report provides historical as well as forecasted Acute ischemic stroke (AIS) epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032.

The DelveInsight Acute ischemic stroke (AIS) report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

Scope of the Report

• The Acute ischemic stroke (AIS) report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• The Acute ischemic stroke (AIS) Epidemiology Report and Model provide an overview of the global trends of Acute ischemic stroke (AIS) in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
• The report provides insight into the historical and forecasted patient pool of Acute ischemic stroke (AIS) in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
• The report helps recognize the growth opportunities in the 7MM for the patient population
• The report assesses the disease risk and burden and highlights the unmet needs of Acute ischemic stroke (AIS)
• The report provides the segmentation of the Acute ischemic stroke (AIS) epidemiology

Report Highlights

• 11-year Forecast of Acute ischemic stroke (AIS) epidemiology
• 7MM Coverage
• Prevalent and Diagnosed Cases of Acute ischemic stroke (AIS)
• Cases of Acute ischemic stroke (AIS) by Mutation Types
• Acute ischemic stroke (AIS) Cases associated with Clinical Manifestations

KOL views

We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

• What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Acute ischemic stroke (AIS)?
• What are the key findings pertaining to the Acute ischemic stroke (AIS) epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2019-2032)?
• What would be the total number of patients of Acute ischemic stroke (AIS) across the 7MM during the forecast period (2019-2032)?
• Among the EU5 countries, which country will have the highest number of patients during the forecast period (2019-2032)?
• At what CAGR the patient population is expected to grow in 7MM during the forecast period (2019-2032)?
• What is the disease risk, burden and unmet needs of Acute ischemic stroke (AIS)?
• What are the currently available treatments of Acute ischemic stroke (AIS)?

Reasons to buy

The Acute ischemic stroke (AIS) Epidemiology report will allow the user to -

• Develop business strategies by understanding the trends shaping and driving the global Acute ischemic stroke (AIS) market
• Quantify patient populations in the global Acute ischemic stroke (AIS) market to improve product design, pricing, and launch plans
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Acute ischemic stroke (AIS) therapeutics in each of the markets covered
• Understand the magnitude of Acute ischemic stroke (AIS) population by its epidemiology
• The Acute ischemic stroke (AIS) Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

Key Assessments

• Patient Segmentation
• Disease Risk & Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population

Contents

1. KEY INSIGHTS

2. EXECUTIVE SUMMARY OF ACUTE ISCHEMIC STROKE (AIS)

3. ACUTE ISCHEMIC STROKE (AIS): DISEASE BACKGROUND AND OVERVIEW

3.1. Introduction
3.2. Sign and Symptoms
3.3. Pathophysiology
3.4. Risk Factors
3.5. Diagnosis

4. PATIENT JOURNEY

5. EPIDEMIOLOGY AND PATIENT POPULATION

5.1. Epidemiology Key Findings
5.2. Assumptions and Rationale: 7MM
5.3. Epidemiology Scenario: 7MM
  5.3.1. Acute ischemic stroke (AIS) Epidemiology Scenario in the 7MM (2019- 2032)
5.4. United States Epidemiology
  5.4.1. Acute ischemic stroke (AIS) Epidemiology Scenario in the United States (2019- 2032)
5.5. EU-5 Country-wise Epidemiology
  5.5.1. Germany Epidemiology
    5.5.1.1. Acute ischemic stroke (AIS) Epidemiology Scenario in Germany (2019- 2032)
  5.5.2. France Epidemiology
    5.5.2.1. Acute ischemic stroke (AIS) Epidemiology Scenario in France (2019- 2032)
  5.5.3. Italy Epidemiology
    5.5.3.1. Acute ischemic stroke (AIS) Epidemiology Scenario in Italy (2019- 2032)
  5.5.4. Spain Epidemiology
    5.5.4.1. Acute ischemic stroke (AIS) Epidemiology Scenario in Spain (2019- 2032)
  5.5.5. United Kingdom Epidemiology
    5.5.5.1. Acute ischemic stroke (AIS) Epidemiology Scenario in the United Kingdom (2019-2032)
5.6. Japan Epidemiology
  5.6.1. Acute ischemic stroke (AIS) Epidemiology Scenario in Japan (2019- 2032)

6. TREATMENT ALGORITHM, CURRENT TREATMENT, AND MEDICAL PRACTICES

6.1. Acute ischemic stroke (AIS) Treatment and Management
6.2. Acute ischemic stroke (AIS) Treatment Algorithm

7. KOL VIEWS

8. UNMET NEEDS

9. APPENDIX

9.1. Bibliography
9.2. Report Methodology

10. DELVEINSIGHT CAPABILITIES

11. DISCLAIMER

12. ABOUT DELVEINSIGHT

*The table of contents is not exhaustive; will be provided in the final report

List Of Tables

LIST OF TABLES

List of Table:
Table 1: Acute ischemic stroke (AIS) Epidemiology in 7MM (2019-2032)
Table 2: Acute ischemic stroke (AIS) Diagnosed and Treatable Cases in 7MM (2019-2032)
Table 3: Acute ischemic stroke (AIS) Epidemiology in the United States (2019-2032)
Table 4: Acute ischemic stroke (AIS) Diagnosed and Treatable Cases in the United States (2019-2032)
Table 5: Acute ischemic stroke (AIS) Epidemiology in Germany (2019-2032)
Table 6: Acute ischemic stroke (AIS) Diagnosed and Treatable Cases in Germany (2019-2032)
Table 7: Acute ischemic stroke (AIS) Epidemiology in France (2019-2032)
Table 8: Acute ischemic stroke (AIS) Diagnosed and Treatable Cases in France (2019-2032)
Table 9: Acute ischemic stroke (AIS) Epidemiology in Italy (2019-2032)
Table 10: Acute ischemic stroke (AIS) Diagnosed and Treatable Cases in Italy (2019-2032)
Table 11: Acute ischemic stroke (AIS) Epidemiology in Spain (2019-2032)
Table 12: Acute ischemic stroke (AIS) Diagnosed and Treatable Cases in Spain (2019-2032)
Table 13: Acute ischemic stroke (AIS) Epidemiology in the United Kingdom (2019-2032)
Table 14: Acute ischemic stroke (AIS) Diagnosed and Treatable Cases in the United Kingdom (2019-2032)
Table 15: Acute ischemic stroke (AIS) Epidemiology in Japan (2019-2032)
Table 16: Acute ischemic stroke (AIS) Diagnosed and Treatable Cases in Japan (2019-2032)

List Of Figures

LIST OF FIGURES

List of Figures
Figure 1 Acute ischemic stroke (AIS) Epidemiology in 7MM (2019-2032)
Figure 2 Acute ischemic stroke (AIS) Diagnosed and Treatable Cases in 7MM (2019-2032)
Figure 3 Acute ischemic stroke (AIS) Epidemiology in the United States (2019-2032)
Figure 4 Acute ischemic stroke (AIS) Diagnosed and Treatable Cases in the United States (2019-2032)
Figure 5 Acute ischemic stroke (AIS) Epidemiology in Germany (2019-2032)
Figure 6 Acute ischemic stroke (AIS) Diagnosed and Treatable Cases in Germany (2019-2032)
Figure 7 Acute ischemic stroke (AIS) Epidemiology in France (2019-2032)
Figure 8 Acute ischemic stroke (AIS) Diagnosed and Treatable Cases in France (2019-2032)
Figure 9 Acute ischemic stroke (AIS) Epidemiology in Italy (2019-2032)
Figure 10 Acute ischemic stroke (AIS) Diagnosed and Treatable Cases in Italy (2019-2032)
Figure 11 Acute ischemic stroke (AIS) Epidemiology in Spain (2019-2032)
Figure 12 Acute ischemic stroke (AIS) Diagnosed and Treatable Cases in Spain (2019-2032)
Figure 13 Acute ischemic stroke (AIS) Epidemiology in the United Kingdom (2019-2032)
Figure 14 Acute ischemic stroke (AIS) Diagnosed and Treatable Cases in the United Kingdom (2019-2032)
Figure 15 Acute ischemic stroke (AIS) Epidemiology in Japan (2019-2032)
Figure 16 Acute ischemic stroke (AIS) Diagnosed and Treatable Cases in Japan (2019-2032)
*The table of contents is not exhaustive; will be provided in the final report